PLSE
Pulse Biosciences Inc
NASDAQ: PLSE · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$21.17
+4.75% today
Updated 2026-04-30
Market cap
$1.48B
P/E ratio
—
P/S ratio
4,240.58x
EPS (TTM)
$-1.08
Dividend yield
—
52W range
$13 – $26
Volume
0.3M
Pulse Biosciences Inc (PLSE) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-6,914.00%
ROE
-74.50%
ROA
-42.40%
Debt/equity
0.09x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2014 | $0.00 | $-474857.00 | — | — | — |
| 2015 | $0.00 | $-2.81M | — | — | — |
| 2016 | $68000.00 | $-9.52M | -977.94% | -14,097.06% | -13,997.06% |
| 2017 | $247000.00 | $-25.57M | -269.23% | -10,451.01% | -10,351.01% |
| 2018 | $0.00 | $-37.55M | — | — | — |
| 2019 | $0.00 | $-45.99M | — | — | — |
| 2020 | $114000.00 | $-49.74M | -960.53% | -43,828.95% | -43,628.95% |
| 2021 | $1.42M | $-63.16M | -38.79% | -4,443.86% | -4,454.16% |
| 2022 | $700000.00 | $-58.95M | -1,606.29% | -8,293.86% | -8,421.86% |
| 2023 | $-9000.00 | $-42.21M | 13,411.11% | 484,155.56% | 469,000.00% |
| 2024 | $0.00 | $-53.59M | — | — | — |
| 2025 | $350000.00 | $-72.78M | -360.00% | -21,982.57% | -20,794.57% |